Pressure BioSciences (OTCMKTS:PBIO) Stock Price Crosses Below 200 Day Moving Average – Should You Sell?

Pressure BioSciences, Inc. (OTCMKTS:PBIOGet Free Report) shares crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.01 and traded as low as $0.00. Pressure BioSciences shares last traded at $0.00, with a volume of 223 shares traded.

Pressure BioSciences Price Performance

The stock has a market capitalization of $193,351.50, a price-to-earnings ratio of 0.00 and a beta of -0.41. The company has a 50-day simple moving average of $0.01 and a two-hundred day simple moving average of $0.01.

Pressure BioSciences (OTCMKTS:PBIOGet Free Report) last released its quarterly earnings data on Friday, February 7th. The company reported ($0.15) earnings per share for the quarter.

About Pressure BioSciences

(Get Free Report)

Pressure BioSciences, Inc develops and sells pressure-based platform solutions in the North America, Europe, and Asia. The company's pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources.

Featured Stories

Receive News & Ratings for Pressure BioSciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pressure BioSciences and related companies with MarketBeat.com's FREE daily email newsletter.